Otitis Media with Effusion (Surdukulant) — Diagnosis, Watchful Waiting, and Tympanostomy Tube Placement

Otitis media with effusion (OME) is defined as the presence of fluid in the middle ear without signs or symptoms of acute infection (no fever, otalgia, or systemic toxicity). The fluid may be serous (thin, watery), mucoid (thick, glue-like), or purulent residual after acute infection has resolved. OME is extremely common in children, with peak incidence between 6 months and 4 years; epidemiologic studies suggest 80-90% of children experience at least one episode by age 4. The condition results from eustachian tube dysfunction leading to negative middle ear pressure and transudation of fluid, which then becomes a sterile inflammatory exudate.

Risk factors include young age, daycare attendance, passive smoke exposure, bottle-feeding (vs. breastfeeding), pacifier use, supine bottle feeding, craniofacial anomalies (cleft palate, Down syndrome), and immune deficiencies. Adenoid hypertrophy contributes through mechanical eustachian tube obstruction and serves as a bacterial reservoir. The hearing loss associated with OME is typically conductive, ranging from 15-40 dB, and may fluctuate. Despite often being asymptomatic, prolonged hearing loss during critical developmental periods may delay speech and language acquisition, affect academic performance, and contribute to behavioral problems.

Diagnosis relies on otoscopy (dull, retracted or bulging tympanic membrane with air-fluid levels or bubbles, decreased mobility), pneumatic otoscopy (gold standard for mobility assessment), tympanometry (Type B or C curves), and audiologic testing in persistent cases. Management follows evidence-based guidelines emphasizing watchful waiting for 3 months in low-risk children, as 75-90% resolve spontaneously. Antibiotics, decongestants, antihistamines, and intranasal steroids have not demonstrated meaningful benefit and are not recommended. Surgical intervention with tympanostomy tubes is indicated for persistent bilateral OME (>3 months) with documented hearing loss ≥25 dB, recurrent acute otitis media (4+ episodes/6 months or 6+ episodes/year), or in at-risk children (developmental delay, cleft palate). Adenoidectomy is added for children >4 years or those requiring revision tube placement.